Mon - Fri 09:00-18:00 0207 060 3773
Email info@boundarycapital.com

Category

Internal News

Boundary Capital launch Impact Life Fund

January 23, 2020,
Boundary Capital has launched the Impact Life Fund – a fund that invests in high-growth, high-impact private technology companies that focus on enriching people’s lives. The Fund will benefit from a diversified, unique portfolio, EIS tax reliefs, and an experienced management team with a proven track record. Consumers, businesses and investors are taking matters into their...
Read More

Looking for Investment. Seed to Series C: Tips for Business Funding

April 29, 2019,
Managing Partner of Boundary Capital Dan Somers took part in this practical webinar hosted by Accountancy Age. Dan joined other guest speakers Marz Ayyad from Oracle NetSuite and Michael McCaw of Accountancy Age to offer their top tips of business funding. You can watch the webinar here:
Read More

David Gee of Boundary Capital announced as 2019 contributor for Impulse Programme

March 25, 2019
Dr David Gee of Boundary Capital talks about being a contributor to the Impulse Programme 2019 at the Maxwell Centre, University of Cambridge. The vision of the programme is to build an Impulse community for innovators and entrepreneurs from a variety of disciplines, industries and countries who are passionate in helping a new generation of...
Read More

Boundary Capital interviewed for Wealth Club Ltd

October 16, 2018
Boundary Capital started as an angel investment club, based on early successes, it creating its AngelPlus EIS and SEIS funds for a wider investor base. Wealth Club Ltd met managing partner Dan Somers to probe our investment style, find out what kind of companies are going into investors’ portfolios, how we manage (and exit) the...
Read More

Boundary Capital Newsletter: Autumn 2018

October 10, 2018
  View From The Pavilion Your newsletter from Boundary Capital. We’re delighted to bring you the latest news and updates from the Boundary Capital portfolio of high-tech movers and shakers. GROWTH INVEST: Adviser Hour – Series 1 Dan Somers, Managing Partner at Boundary Capital talks to Lawrence Gosling, Editor-in-Chief at GrowthBusiness.com on the GrowthInvest Adviser...
Read More

Boundary discusses the EIS market on GrowthInvest Advisor Hour

September 19, 2018,
Managing Partner of Boundary Capital, Dan Somers, was recently interviewed by and joined a panel of experts on, the GrowthInvest Adviser Hour. GrowthInvest is the tax efficient investment platform for financial advisers and high net worth and sophisticated investors, is delighted to present, in association with Capital Connections. Now into its second series, the program...
Read More

Boundary Capital exits Image Scan to realise gain for investors

March 14, 2018,
Boundary Capital has announced its exit for the bulk of its holdings in AIM listed Image Scan Holdings Plc. The exit has returned four times the original investment for investors, after only three years. Boundary Capital has invested in a number of assets in technology and life sciences covering big data analytics, left science therapeutics...
Read More

Boundary Capital in the Press: Finance Digital, Why Some Investors Are Going The Extra Mile

December 22, 2017,
Our Managing Partner Dan Somers talks to Finance Digital talking about why some investors are going the extra mile. Investing in early stage technology businesses is a risky business. If you get it right investing in a disruptive business like WhatsApp or Alibaba can generate huge exits: a whopping $22Bn and $25Bn respectively (Sequoia Capital turned...
Read More

Image Scan share price grows more than five-fold with Boundary Capital

October 30, 2017,
Boundary Capital has seen the price of its shares in Image Scan Holdings plc grow by five and a half times since their initial investment three years ago due to the stellar development and growth of Image Scan. Image Scan, the specialist supplier of X-ray screening systems to the security and industrial inspection markets is...
Read More

Boundary in the Press: What Investment, AB-Polyblok files for patent of potentially revolutionary dementia drug

October 12, 2017,
What Investment has published the latest news from Boundary Capital’s portfolio company AB Polyblok. Boundary Capital investment company AB-Polyblok has today filed a patent application following the results of in-vitro & in-vivo experiments that have shown that their drug appears to reverse the effects of the key misfolded proteins associated with all three dementia diseases...
Read More
1 2 3 4

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases